Dissemination: The fatal risk for a missed diagnosis of Strongyloides stercoralis infection
- 1 September 2007
- journal article
- Published by Elsevier in Journal of Infection
- Vol. 55 (3) , 284-285
- https://doi.org/10.1016/j.jinf.2007.01.009
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Evaluation of an Indirect Immunofluorescence Assay for Strongyloidiasis as a Tool for Diagnosis and Follow-UpClinical and Vaccine Immunology, 2007
- Severe strongyloidiasis in corticosteroid-treated patients: Case series and literature reviewJournal of Infection, 2007
- Utility of serological follow-up of chronic strongyloidiasis after anthelminthic chemotherapyTransactions of the Royal Society of Tropical Medicine and Hygiene, 2006
- Unsuspected strongyloidiasis in hospitalised elderly patients with and without eosinophiliaClinical Microbiology & Infection, 2006
- Strongyloides stercoralisin the Immunocompromised PopulationClinical Microbiology Reviews, 2004
- Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area.The American Journal of Tropical Medicine and Hygiene, 2002
- The value of an immunoenzymatic test (enzyme-linked immunosorbent assay) for the diagnosis of strongyloidiasis in patients immunosuppressed by hematologic malignancies.The American Journal of Tropical Medicine and Hygiene, 2001
- Diagnosis ofStrongyloides stercoralisInfectionClinical Infectious Diseases, 2001
- Treatment of Strongyloides stercoralis infection with ivermectin compared with albendazole: results of an open study of 60 casesTransactions of the Royal Society of Tropical Medicine and Hygiene, 1994
- A Randomized Trial of Single- and Two-Dose Ivermectin versus Thiabendazole for Treatment of StrongyloidiasisThe Journal of Infectious Diseases, 1994